BioEcho Life Sciences was founded in 2016 by a team with many years of experience in R&D and marketing/distribution of molecular biological products. The company focuses on the extraction and processing of nucleic acids (DNA, RNA) for applications in genomic research and molecular diagnostics as well as in forensics and food testing.

BioEcho has developed a one-step technology for significantly accelerated and dramatically simplified purification of nucleic acids. Based on this technology, the company offers the first products of a new generation of molecular biology kits and reagents. These make it possible to isolate genomic DNA from various biological sample materials such as blood, cells and tissues with higher quality and two to four times faster and while avoiding 70% laboratory waste compared to conventional kits.

The company plans to use its toolbox and technologies in the area of genomic sample preparation to develop modern and faster methods in the areas of liquid biopsies (isolation of cell-free circulating nucleic acids), sequencing workflows (NGS), and systems for molecular and point-of-care diagnostics.